ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements
Southern Magnesium & Chemicals says it need not file related party disclosures under Regulation 23(9). Its capital and net worth are below the exemption limits.
Southern Magnesium & Chemicals reported unaudited quarter and half-year results to 30 September 2026, with a half-year loss before tax of Rs 53.15 lakhs. The filing includes the limited review report, balance sheet and cash flow statement.
Southern Magnesium and Chemicals announced the cessation of Mr. Rama Krishna Maram as Nominee Director effective November 3, 2026. This follows the withdrawal of his nomination by APIDC.
Southern Magnesium & Chemicals Ltd scheduled a Board Meeting on 06 Nov 2026 to approve Q3 FY27 results. Trading window closed from 1 Oct 2026.
Southern Magnesium and Chemicals Ltd announced the conclusion of tax proceedings by the Special Circle, Rajamahendravaram, resulting in zero tax demand on the company.
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Shareholders of Southern Magnesium & Chemicals Ltd rejected the redesignation of Mr. Nuthakki Rajender Prasad. He continues in his current roles as Joint Managing Director and CFO.
Southern Magnesium & Chemicals Limited held its 40th Annual General Meeting on 30.09.2026 via video conferencing. Voting results will be submitted separately.
Southern Magnesium and Chemicals Limited will hold its 40th AGM on September 30, 2026. The meeting will be conducted via video conferencing to transact business matters.
Southern Magnesium & Chemicals Ltd reported revenue from operations of ₹0.3 Cr (+50.0% YoY) and a net loss of ₹0.5 Cr for Q1 FY27.
Southern Magnesium and Chemicals has scheduled a board meeting for August 7, 2026. The board will consider unaudited quarterly financial results and AGM-related matters.
Southern Magnesium & Chemicals Ltd confirmed the non-applicability of SEBI Regulation 23(9) regarding related party transaction disclosures. The company is exempt as its paid-up share capital and net worth remained below ₹10 Crore and ₹25 Crore, respectively, as of March 31, 2025. This is a routine regulatory compliance update.
Southern Magnesium & Chemicals Ltd reported revenue from operations of ₹0.9 Cr (+12.5% YoY) and net profit of ₹0.1 Cr for Q4 FY26.
Southern Magnesium and Chemicals Limited approved its audited financial results for the year ended March 31, 2026. The company reported a total annual income of ₹3.99 Crore and a net profit of ₹0.13 Crore. Additionally, the board appointed D. Hanumanta Raju & Co. as secretarial auditors and K. S. Rao & Co. as internal auditors for FY 2026-27.
Southern Magnesium & Chemicals Ltd has scheduled a Board Meeting on May 4, 2026. The board will consider and approve the audited financial results for the quarter and year ended March 31, 2026. The trading window remains closed until 48 hours after the results announcement.
Southern Magnesium and Chemicals Limited has opened a special one-year window from February 5, 2026, to February 4, 2027, for the transfer and dematerialisation of physical securities. This facility applies to investors who purchased physical shares before April 01, 2019, subject to specific SEBI conditions.
Southern Magnesium and Chemicals Ltd clarified to BSE that recent share price movements are market-driven. The company confirmed it has made all necessary disclosures under SEBI regulations and holds no undisclosed price-sensitive information.
Southern Magnesium and Chemicals Limited confirmed it does not qualify as a 'Large Corporate' under SEBI's framework for the financial year. The company reported outstanding borrowings of ₹4.67 Crore as of March 31, 2026. This mandatory regulatory disclosure ensures compliance with debt-raising norms for listed entities.